Bhash Naidoo

480 total citations
15 papers, 238 citations indexed

About

Bhash Naidoo is a scholar working on General Health Professions, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Bhash Naidoo has authored 15 papers receiving a total of 238 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in General Health Professions, 7 papers in Economics and Econometrics and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Bhash Naidoo's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Healthcare cost, quality, practices (4 papers) and Health disparities and outcomes (3 papers). Bhash Naidoo is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Healthcare cost, quality, practices (4 papers) and Health disparities and outcomes (3 papers). Bhash Naidoo collaborates with scholars based in United Kingdom, United States and Australia. Bhash Naidoo's co-authors include Peter Littlejohns, Kalipso Chalkidou, Anthony J. Culyer, Ian R. White, Duolao Wang, Colin Sanderson, Sophie Beale, Kathryn McPherson, L.J. Gunning-Schepers and Margaret Thorogood and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Oncology and Journal of Clinical Epidemiology.

In The Last Decade

Bhash Naidoo

14 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bhash Naidoo United Kingdom 10 104 81 39 31 31 15 238
Néboa Zozaya Spain 10 106 1.0× 96 1.2× 49 1.3× 20 0.6× 56 1.8× 45 372
Aixia Ma China 8 115 1.1× 99 1.2× 29 0.7× 19 0.6× 11 0.4× 19 298
Shuli Qu China 11 47 0.5× 64 0.8× 60 1.5× 42 1.4× 50 1.6× 31 403
Jiaoling Huang China 10 108 1.0× 125 1.5× 29 0.7× 11 0.4× 10 0.3× 47 322
Kushal T. Kadakia United States 11 86 0.8× 94 1.2× 44 1.1× 8 0.3× 33 1.1× 48 300
Kim Edmunds Australia 9 63 0.6× 100 1.2× 61 1.6× 47 1.5× 29 0.9× 19 302
Nazan Yardım Türkiye 8 86 0.8× 271 3.3× 27 0.7× 27 0.9× 28 0.9× 22 424
Deanna B. McQuillan United States 8 111 1.1× 190 2.3× 39 1.0× 18 0.6× 8 0.3× 12 332
Mahlet G. Tebeka United States 10 91 0.9× 72 0.9× 29 0.7× 11 0.4× 13 0.4× 17 287
Amanda Cole United Kingdom 12 174 1.7× 84 1.0× 43 1.1× 16 0.5× 16 0.5× 44 357

Countries citing papers authored by Bhash Naidoo

Since Specialization
Citations

This map shows the geographic impact of Bhash Naidoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhash Naidoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhash Naidoo more than expected).

Fields of papers citing papers by Bhash Naidoo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhash Naidoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhash Naidoo. The network helps show where Bhash Naidoo may publish in the future.

Co-authorship network of co-authors of Bhash Naidoo

This figure shows the co-authorship network connecting the top 25 collaborators of Bhash Naidoo. A scholar is included among the top collaborators of Bhash Naidoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhash Naidoo. Bhash Naidoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Naidoo, Bhash, S Pillay, & Douglas Wilson. (2024). Interrelations between metformin administration and vitamin B12 concentrations in a black South African diabetic cohort: a retrospective cohort analysis. Journal of Endocrinology Metabolism and Diabetes of South Africa. 29(2). 43–47.
2.
3.
Bauer, Annette, Michela Tinelli, Helen Weatherly, et al.. (2021). Value for Money in Social Care: The Role of Economic Evidence in the Guideline Development Process of the National Institute for Health and Care Excellence in England. SHILAP Revista de lepidopterología. 303–317. 2 indexed citations
4.
Jaime, J., et al.. (2020). Leveraging DICE (Discretely-Integrated Condition Event) Simulation to Simplify the Design and Implementation of Hybrid Models. Value in Health. 23(8). 1049–1055. 3 indexed citations
5.
Griffin, Susan, Francesco Fusco, Bhash Naidoo, Matthew Taylor, & Simon Walker. (2020). Does Health Technology Assessment guidance give adequate consideration to decisions about less costly and less effective alternatives. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 1 indexed citations
6.
Caldwell, Deborah M, A. E. Ades, Sofia Dias, et al.. (2016). A threshold analysis assessed the credibility of conclusions from network meta-analysis. Journal of Clinical Epidemiology. 80. 68–76. 18 indexed citations
7.
Sharma, Tarang, et al.. (2015). EVIDENCE INFORMED DECISION MAKING: THE USE OF “COLLOQUIAL EVIDENCE” AT NICE. International Journal of Technology Assessment in Health Care. 31(3). 138–146. 26 indexed citations
8.
Akaza, Hideyuki, N. Kawahara, Jae Kyung Roh, et al.. (2014). Japanese Cancer Association Meeting UICC International Session - What is Cost-effectiveness in Cancer Treatment?. Asian Pacific Journal of Cancer Prevention. 15(1). 3–10. 3 indexed citations
9.
Naidoo, Bhash, et al.. (2013). NICE guidance on pirfenidone for treating idiopathic pulmonary fibrosis. The Lancet Respiratory Medicine. 1(3). 191–192. 15 indexed citations
10.
Beale, Sophie, et al.. (2012). Should we invest in environmental interventions to encourage physical activity in England? An economic appraisal. European Journal of Public Health. 22(6). 869–873. 20 indexed citations
11.
Dillon, B.M., Bhash Naidoo, Helen Knight, & Peter Clark. (2012). NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer. The Lancet Oncology. 13(8). 764–765. 13 indexed citations
12.
Chalkidou, Kalipso, Anthony J. Culyer, Bhash Naidoo, & Peter Littlejohns. (2007). Cost‐effective public health guidance: asking questions from the decision‐maker's viewpoint. Health Economics. 17(3). 441–448. 33 indexed citations
13.
Sanderson, Colin, et al.. (2002). The Development of a Simulation Model of Primary Prevention Strategies for Coronary Heart Disease. Health Care Management Science. 5(4). 269–274. 28 indexed citations
15.
Naidoo, Bhash, Margaret Thorogood, Kathryn McPherson, & L.J. Gunning-Schepers. (1997). Modelling the effects of increased physical activity on coronary heart disease in England and Wales.. Journal of Epidemiology & Community Health. 51(2). 144–150. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026